Sanuwave outlines Q3 revenue pressure amid pivot to hospital pressure injury market
FROM THE WIRE · SEEKINGALPHA.COM
Earnings Call Insights: SANUWAVE Health (SNWV) Q3 2026 MANAGEMENT VIEW * Morgan Frank (CEO & Chairman) framed the quarter around CMS reimbursement changes, saying, "Q3 was really the story of the CMS proposed rule" and that "its effects were profound," citing customer disruption…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishLower applicator and UltraMIST system sales weigh on the results of a small medical device maker.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01CEO Morgan Frank attributes the quarter to CMS reimbursement changes.
- 02Applicator revenue declined about 4% in Q3 versus Q2.
- 03UltraMIST system sales dropped from 82 to 40.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets